JP2022505183A5 - - Google Patents

Info

Publication number
JP2022505183A5
JP2022505183A5 JP2021521129A JP2021521129A JP2022505183A5 JP 2022505183 A5 JP2022505183 A5 JP 2022505183A5 JP 2021521129 A JP2021521129 A JP 2021521129A JP 2021521129 A JP2021521129 A JP 2021521129A JP 2022505183 A5 JP2022505183 A5 JP 2022505183A5
Authority
JP
Japan
Prior art keywords
combination according
pharmaceutically acceptable
antiviral agent
pyrrolo
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021521129A
Other languages
English (en)
Japanese (ja)
Other versions
JP7577652B2 (ja
JP2022505183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056632 external-priority patent/WO2020081751A1/en
Publication of JP2022505183A publication Critical patent/JP2022505183A/ja
Publication of JP2022505183A5 publication Critical patent/JP2022505183A5/ja
Application granted granted Critical
Publication of JP7577652B2 publication Critical patent/JP7577652B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521129A 2018-10-17 2019-10-17 インフルエンザウイルス複製の阻害剤の組み合わせ Active JP7577652B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746884P 2018-10-17 2018-10-17
US62/746,884 2018-10-17
PCT/US2019/056632 WO2020081751A1 (en) 2018-10-17 2019-10-17 Combinations of inhibitors of influenza virus replication

Publications (3)

Publication Number Publication Date
JP2022505183A JP2022505183A (ja) 2022-01-14
JP2022505183A5 true JP2022505183A5 (https=) 2022-10-21
JP7577652B2 JP7577652B2 (ja) 2024-11-05

Family

ID=68503202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521129A Active JP7577652B2 (ja) 2018-10-17 2019-10-17 インフルエンザウイルス複製の阻害剤の組み合わせ

Country Status (17)

Country Link
US (1) US12233066B2 (https=)
EP (1) EP3866778B1 (https=)
JP (1) JP7577652B2 (https=)
KR (1) KR102890706B1 (https=)
CN (1) CN112969457B (https=)
AU (1) AU2019361038B2 (https=)
BR (1) BR112021007275A2 (https=)
CA (1) CA3115823A1 (https=)
DK (1) DK3866778T3 (https=)
ES (1) ES2939148T3 (https=)
FI (1) FI3866778T3 (https=)
IL (1) IL282018B2 (https=)
MX (1) MX2021004215A (https=)
PL (1) PL3866778T3 (https=)
PT (1) PT3866778T (https=)
TW (1) TWI829785B (https=)
WO (1) WO2020081751A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230158020A1 (en) * 2020-05-23 2023-05-25 Alexandre Vasilievich Ivaschenko Method for treating RNA viral infections, including COVID-19 (SARS-CoV-2)
WO2022074630A1 (en) * 2020-10-09 2022-04-14 Auxilla Pharmaceuticals And Research Llp Liquid oral suspension of favipiravir
CN113413365B (zh) * 2021-07-30 2022-11-22 合肥医工医药股份有限公司 一种稳定的法维拉韦口服溶液制剂及其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
GB2064336B (en) 1979-12-06 1984-03-14 Glaxo Group Ltd Device for dispensing medicaments
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4353656A (en) 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GB2129691B (en) 1982-10-08 1987-08-05 Glaxo Group Ltd Devices for administering medicaments to patients
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US4753788A (en) 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
CA2070823C (en) 1989-12-05 1999-01-12 William H. Ii Frey Neurologic agents for nasal administration to the brain
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
AU6526100A (en) 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
US6632666B2 (en) 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
JP2005504715A (ja) 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ,インコーポレイテッド 持続放出特性を有する吸入用粒子
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
AU2002352836B2 (en) 2001-11-20 2005-09-29 Alkermes, Inc. Improved particulate compositions for pulmonary delivery
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
EP1673123A2 (en) 2003-09-05 2006-06-28 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
SG11201804348SA (en) 2015-12-15 2018-06-28 Shionogi & Co Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
CN108276401B (zh) * 2017-01-05 2020-12-22 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
WO2018157830A1 (en) * 2017-03-02 2018-09-07 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
TWI778052B (zh) * 2017-04-24 2022-09-21 美商共結晶製藥公司 流感病毒複製之抑制劑

Similar Documents

Publication Publication Date Title
HRP20191957T1 (hr) Policiklični-karbamoilpiridonski spojevi i njihova farmaceutska upotreba
JP2022505183A5 (https=)
JP2013543896A5 (https=)
JP2015534562A5 (https=)
JP2018188483A5 (https=)
HRP20231018T1 (hr) Terapeutski spojevi korisni za profilaktičko ili terapijsko liječenje hiv virusne infekcije
US20090247570A1 (en) Pharmaceuticals
HRP20230274T1 (hr) Kemijski spojevi
HRP20211543T1 (hr) Derivati kinazolina koji se koriste za liječenje hiv-a
JP2014521735A5 (https=)
JP2015038149A5 (https=)
EA038122B9 (ru) Ингибитор поверхностного антигена вируса гепатита b
HRP20171808T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova uporaba za liječenje hiv infekcija
JP2016508134A5 (https=)
JP2012532874A5 (https=)
JP2017528503A5 (https=)
JP2015512406A5 (https=)
JP2018168191A5 (https=)
FI3866778T3 (fi) Influenssa viruksen replikaation estäjien yhdistelmät
HRP20211749T1 (hr) Pentanske kiseline supstituirane pirolo-[2-3,b]pirimidin-piridinima za liječenje virusnih infekcija influencom
JP2020529995A5 (https=)
EP4066839A4 (en) PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS
JP2021073257A5 (https=)
HRP20241716T1 (hr) Postupci liječenja promjena u ponašanju
JP2020510075A5 (https=)